產(chǎn)品描述
40 PACKAGES 2612 CARTONS PHA RMACEUTICALS AS UNDER CLIND AMYCIN HCL CAP 300MG 100 NDC CODE:68462014401 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941.90.5000 ANDA NO.: 216957 THERAPEUTICE USE: :#T REATMENT OF NUMEROUS INFECTIO NS, INCLUDING BUT NOT LIMITE D TO SEPTICEMIA,INTRAABDOMINA L INFECTIONS, LOWER RESPIRAT ORY INFECTIONS, GYNECOLOGICAL INFECTIONS, BONE AND JOINT INFECTIONS, AND SKIN AND SKIN STRUCTURE INFECTIONS METF ORMIN HCL ER TAB (Z) 500MG 100 NDC CODE:68462052001 FDA PR ODUCT CODE NO.: 61 P C A 55 H. T. S NO.: 3004.90.92.40 A NDA NO.:212969 THERAPEUTICE U SE: THE MANAGEMENT OF TYPE 2 DIABETES GABAPENTIN TAB 60 0MG 500 NDC CODE:68462012605 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT PIMECRO LIMUS CREAM 1% 100GM NDC CODE :68462060994 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO .: 3004.90.92.45 ANDA NO.: 2 11769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NON- IMMUNOCOMPROMISED A DULT AND CHILDREN 2 YEARS OF AGE TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THER APEUTIC USE : TO PREVENT REJE CTION OF A KIDNEY,HEART, OR L IVER TRANSPLANT TACROLIMUS CAP 5MG 100 NDC CODE:6846206 8701 HTS NO: 3004.90.92.15 F DA CODE : 64 T C E 08 ANDA NO .206662 THERAPEUTICE USE: TO PREVENT REJECTION OF A KIDNE Y, HEART, OR LIVER TRANSPLANT TACROLIMUS OINTMENT 0.03% 30GM NDC CODE:68462088135 FD A PRODUCT CODE NO.:64 T C J 0 8 H. T. S NO.: 3004.49.0050 ANDA NO.:210393 THERAPEUTICE USE: TOPICAL IMMUNOSUPPRESS IVE AGENT TACROLIMUS OINTM ENT 0.03% 60GM NDC CODE:68462 088165 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 300 4.49.0050 ANDA NO.:210393 TH ERAPEUTICE USE: TOPICAL IMMU NOSUPPRESSIVE AGENT PIMECR OLIMUS CREAM 1% 60GM NDC CODE :68462060965 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO .: 3004.90.92.45 ANDA NO.: 2 11769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NON- IMMUNOCOMPROMISED A DULT AND CHILDREN 2 YEARS OF AGE COMMERCIAL & CUSTOM I NVOICE NO. F22687000293 DT. 1 9.05.2025 F22687000296 DT. 19 .05.2025 F22687000297 DT. 19. 05.2025 F22687000301 DT. 19.0 5.2025 S/BILL NO:1961056 DT:1 9-MAY-25 S/BILL NO:1961053 DT :19-MAY-25 S/BILL NO:1961042 DT:19-MAY-25 S/BILL NO:196104 4 DT:19-MAY-25 GROSS WT. 8,70 6.626 KGS NET WT.4586.718 KGS 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA 展開
交易日期
2025/06/23
提單編號
maeu253901504
供應(yīng)商
glenmark pharmaceuticals inc.
采購商
glenmark pharmaceuticals inc.
出口港
52330, salalah
進(jìn)口港
4601, new york/newark area, newark, nj
產(chǎn)品描述
PART OF FCL 42 PACKAGES 17 54 CARTONS PHARMACEUTICALS AS UNDER TACROLIMUS OINTMENT 0.03% 60GM NDC CODE:684620881 65 FDA PRODUCT CODE NO.:64 T C J 08 H. T. S NO.: 3004.49 .0050 ANDA NO.:210393 THERAP EUTICE USE: TOPICAL IMMUNOSU PPRESSIVE AGENT CLINDAMYCI N HCL CAP 300MG 100 NDC CODE: 68462014401 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941.90.5000 ANDA NO.:21695 7 THERAPEUTICE USE: :#TREATM ENT OF NUMEROUS INFECTIONS, I NCLUDING BUT NOT LIMITED TO SEPTICEMIA,INTRAABDOMINAL IN FECTIONS, LOWER RESPIRATORY INFECTIONS, GYNECOLOGICAL INF ECTIONS, BONE AND JOINT INFEC TIONS, AND SKIN AND SKIN STRU CTURE INFECTIONS COLESEVEL AM HCL TAB 625MG 180 NDC CODE :68462043318 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO .: 3004.49.00.10 ANDA NO.: 2 03480 THERAPEUTICE USE: - AN TIHYPERLIPO PROTEINEMIC. G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO. 3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVU LSANT COMMERCIAL & CUSTOM I NVOICE NO. F22687000269 DT. 1 4.05.2025 F22687000270 DT. 14 .05.2025 F22687000271 DT. 14. 05.2025 S/BILL NO:1854088 DT: 15-MAY-25 S/BILL NO:1854100 DT:15-MAY-25 S/BILL NO:185410 4 DT:15-MAY-25 GROSS WT. 9,09 6.838 KGS NET WT.5784.823 KGS 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA 展開
交易日期
2025/06/23
提單編號
maeu253741885
供應(yīng)商
glenmark pharmaceuticals inc.
采購商
glenmark pharmaceuticals inc.
出口港
52330, salalah
進(jìn)口港
4601, new york/newark area, newark, nj
產(chǎn)品描述
28 PACKAGES 1972 CARTONS PHA RMACEUTICALS AS UNDER PRAMI PEXOLE TAB 0.25MG 90 NDC CODE :68462033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO .: 3004.90.92.40 ANDA NO.: 9 0-781 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE. CA RVEDILOL TAB 25MG 500 NDC COD E:68462016505 FDA PRODUCT COD E NO :62 O C A 22 HTS NO.300 4.90.9221 ANDA NO.78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST ZONISAMI DE CAP 100MG 100 NDC CODE:684 62013001 FDA PRODUCT CODE NO .:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO.:-77-65 1 THERAPEUTICE USE:-ANTISEIZ URE DRUG CARVEDILOL TAB 25M G 500 NDC CODE:68462016505 F DA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST HEATHER TAB 0.35MG 84 N DC CODE:68462030329 FDA PRODU CT CODE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.:90-454 THERAPEUTICE USE: PREVENTION OF PREGNANCY. COMMERCIAL & CUSTOM INVOICE NO . F22652000766 DT. 16.05.2025 F22652000767 DT. 16.05.2025 F22652000782 DT. 16.05.2025 F22652000783 DT. 16.05.2025 F 22652000780 DT. 16.05.2025 S/ BILL NO: 1920008 DT 17-MAY-202 5 S/BILL NO: 1921515 DT 17-MA Y-2025 S/BILL NO: 1919793 DT 17-MAY-2025 S/BILL NO: 192211 6 DT 17-MAY-2025 S/BILL NO: 1 917344 DT 17-MAY-2025 GROSS WT. 6,613.151 KGS NET WT.545 3.873 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA 展開
交易日期
2025/06/23
提單編號
maeu254051397
供應(yīng)商
glenmark pharmaceuticals inc.
采購商
glenmark pharmaceuticals inc.
出口港
52330, salalah
進(jìn)口港
4601, new york/newark area, newark, nj
產(chǎn)品描述
28 PACKAGES 1449 CARTONS PHA RMACEUTICALS AS UNDER HEATH ER TAB 0.35MG 84 NDC CODE:684 62030329 FDA PRODUCT CODE NO. : 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.:90-454 THERAPEUTICE USE: PREVENTIO N OF PREGNANCY. IMIQUIMOD C REAM 5% 0.25GM 24 NDC CODE:68 462053670 FDA PRODUCT CODE NO .: 62 V C J 29 H. T. S NO.: 3004.49.00.50 ANDA NO.:20199 4 THERAPEUTICE USE: - INDICA TED FOR ACTINIC KERATOSES AND EXTERNAL GENITAL AND PERIAN AL WARTS GABAPENTIN TAB 600 MG 100 NDC CODE:68462012601 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 AND A NO.:-77-662 THERAPEUTICE U SE:-ANTICONVULSANT GABAPENT IN TAB 600MG 500 NDC CODE:684 62012605 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90 .9236 ANDA NO.:-77-662 THERA PEUTICE USE:-ANTICONVULSANT COMMERCIAL & CUSTOM INVOICE NO. F22652000758 DT. 15.05.20 25 F22652000750 DT. 14.05.202 5 F22652000760 DT. 15.05.2025 S/BILL NO: 1861722 DT 15-MAY -2025 S/BILL NO: 1861733 DT 1 5-MAY-2025 S/BILL NO: 1866240 DT 15-MAY-2025 GROSS WT. 4,9 04.970 KGS NET WT.3783.150 KG S 02 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA 展開
交易日期
2025/06/23
提單編號
maeu254208262
供應(yīng)商
glenmark pharmaceuticals inc.
采購商
glenmark pharmaceuticals inc.
出口港
52330, salalah
進(jìn)口港
4601, new york/newark area, newark, nj
產(chǎn)品描述
PART OF FCL 14 PACKAGES 16 37CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 40MG 500 NDC CODE:68462026405 61 J C A 16 3004.49.00.10 7917 2 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND T O PREVENT CARDIOVASCULAR DISE ASE ROSUVASTATIN TAB 40MG 3 0 NDC CODE:68462026430 FDA P RODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 A NDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTE ROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 4 0MG 30 NDC CODE:68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00. 10 ANDA NO.: 079172 THERAPEU TICE USE: - TO TREAT HIGH CHO LESTEROL AND RELATED CONDITIO NS, AND TO PREVENT CARDIOVAS CULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F226520007 68 DT. 16.05.2025 F2265200078 1 DT. 16.05.2025 S/BILL NO: 1 919789 DT 17-MAY-2025 S/BILL NO: 1919807 DT 17-MAY-2025 GR OSS WT. 3,649.116 KGS NET WT. 2955.054 KGS 14 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCH ATEL - 2000 SWITZERLAND 展開
交易日期
2025/06/23
提單編號
maeu254037875
供應(yīng)商
glenmark pharmaceuticals inc.
采購商
glenmark pharmaceuticals inc.
出口港
52330, salalah
進(jìn)口港
4601, new york/newark area, newark, nj
產(chǎn)品描述
PART OF FCL 1 PACKAGES 20 CARTONS PHARMACEUTICALS AS UN DER NITROGLYCERIN SUBLING T AB 0.6MG 100 NDC CODE:6846206 4001 FDA PRODUCT CODE NO.:66 S C A 28 H. T. S NO.: 3004. 90.9020 ANDA NO.:206391 THER APEUTICE USE: :#MEDICATION US ED FOR HEART FAILURE,HIGH BLO OD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEAR T COMMERCIAL & CUSTOM INVO ICE NO. F22687000272 DT. 14.0 5.2025 S/BILL NO: 1854090 DT: 15-MAY-25 GROSS WT. 117.149 K GS NET WT.10.570 KGS 01 DATA LOGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK SPECIALTY S.A. SWITZE RLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND 展開
交易日期
2025/06/23
提單編號
maeu254178145
供應(yīng)商
mankind pharma ltd.
采購商
glenmark pharmaceuticals inc.
出口港
52330, salalah
進(jìn)口港
4601, new york/newark area, newark, nj
產(chǎn)品描述
PART OF FCL 16 PACKAGES 18 17 CARTONS PHARMACEUTICALS AS UNDER VARENICLINE TABLETS 1 MG, 56CT NDC NO. : 68462-89 4-56 FDA PRODUCT CODE : 65ZCA 01 ANDA NO. : 214255 H. T. S NO.: 3004.90.99 THERAPEUTIC USE : USE AS AN AID TO SMOK ING CESSATION TREATMENT VAR ENICLINE TABLETS 1 MG, 56CT N DC NO. : 68462-894-56 FDA PRO DUCT CODE : 65ZCA01 ANDA NO. : 214255 H. T. S NO.: 3004.9 0.99 THERAPEUTIC USE : USE AS AN AID TO SMOKING CESSATION TREATMENT VARENICLINE TABL ETS 1 MG, 56CT NDC NO. : 6846 2-894-56 FDA PRODUCT CODE : 6 5ZCA01 ANDA NO. : 214255 H. T. S NO.: 3004.90.99 THERAPE UTIC USE : USE AS AN AID TO SMOKING CESSATION TREATMENT VARENICLINE TABLETS 1 MG, 56C T NDC NO. : 68462-894-56 FDA PRODUCT CODE : 65ZCA01 ANDA NO. : 214255 H. T. S NO.: 30 04.90.99 THERAPEUTIC USE : USE AS AN AID TO SMOKING CESSA TION TREATMENT COMMERCIAL & CUSTOM INVOICE NO. 832436426 DTD 15.05.2025 S/BILL NO: 19 52773 DT: 19/05/2025 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA 展開
交易日期
2025/06/23
提單編號
maeu253901512
供應(yīng)商
glenmark pharmaceuticals inc.
采購商
glenmark pharmaceuticals inc.
出口港
52330, salalah
進(jìn)口港
4601, new york/newark area, newark, nj
產(chǎn)品描述
49 PACKAGES 2614 CARTONS PHA RMACEUTICALS AS UNDER CARVE DILOL TAB 25MG 500 NDC CODE:6 8462016505 FDA PRODUCT CODE N O :62 O C A 22 HTS NO.3004.9 0.9221 ANDA NO.78-251 THERAP EUTICE USE:-BETA- ADRENOACEP TOR ANTAGONIST OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:684 62039710 FDA PRODUCT CODE NO .:62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GA STROESOPHAGEAL REFLUX DISEASE OXCARBAZEPINE TAB 150MG 10 0 NDC CODE:68462013701 FDA P RODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 ANDA NO. :-77-802 THERAPEUTICE USE:-AN TI CONVULSANT AGENT PRAMIP EXOLE TAB 1MG 90 NDC CODE:684 62033390 FDA PRODUCT CODE NO. : 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-78 1 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE DROSPIR ENONE/EE TAB 3/0.03MG 84 NDC CODE:68462073329 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO .: 204848 THERAPEUTICE USE: - CONTRACEPTION TO PREVENT PR EGNANCY OMEPRAZOLE DR CAP 4 0MG 1000 NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF1 0 HTS NO.3004.90.9255 ANDA N O.:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOP HAGEAL REFLUX DISEASE OXCA RBAZEPINE TAB 150MG 100 NDC C ODE:68462013701 FDA PRODUCT C ODE NO.:-61 M C A 45 HTS NO. 3004.90.9236 ANDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONV ULSANT AGENT PRAMIPEXOLE TA B 1MG 90 NDC CODE:68462033390 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90. 92.40 ANDA NO.: 90-781 THERA PEUTICE USE: USED IN PARKINSO N#S DISEASE INDOMETHACIN CA P 25MG 100 NDC CODE:684620406 01 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:91-276 THER APEUTICE USE: -ANTI-INFLAMATO RY COMMERCIAL & CUSTOM IN VOICE NO. F22652000806 DT. 17 .05.2025 F22652000808 DT. 17. 05.2025 F22652000807 DT. 17.0 5.2025 F22652000818 DT. 18.05 .2025 F22652000819 DT. 18.05. 2025 S/BILL NO: 1941558 DT 19 -MAY-2025 S/BILL NO: 1941911 DT 19-MAY-2025 S/BILL NO: 194 6821 DT 19-MAY-2025 S/BILL NO : 1941571 DT 19-MAY-2025 S/BI LL NO: 1944952 DT 19-MAY-2025 GROSS WT. 10,520.723 KGS N ET WT.8883.685 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +18 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA 展開
交易日期
2025/06/23
提單編號
maeu253901144
供應(yīng)商
glenmark pharmaceuticals inc.
采購商
glenmark pharmaceuticals inc.
出口港
52330, salalah
進(jìn)口港
4601, new york/newark area, newark, nj
產(chǎn)品描述
44 PACKAGES 3026 CARTONS PHA RMACEUTICALS AS UNDER ONDAN SETRON ODT 4MG 30UD NDC CODE: 68462015713 FDA PRODUCT CODE NO,:-61 T C A 26 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -152 THERAPEUTICE USE:-ANTI -EMETIC PRAMIPEXOLE TAB 0.2 5MG 90 NDC CODE:68462033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92 .40 ANDA NO.: 90-781 THERAPE UTICE USE: USED IN PARKINSON# S DISEASE OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:684620396 10 FDA PRODUCT CODE NO.:62KC F10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GASTROES OPHAGEAL REFLUX DISEASE OM EPRAZOLE DR CAP 40MG 1000 NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 HTS NO.300 4.90.9255 ANDA NO.:91672 THE RAPEUTICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUST OM INVOICE NO. F22652000795 D T. 17.05.2025 F22652000787 DT . 17.05.2025 F22652000804 DT. 17.05.2025 S/BILL NO: 192324 6 DT 17-MAY-2025 S/BILL NO: 1 922769 DT 17-MAY-2025 S/BILL NO: 1944089 DT 19-MAY-2025 GR OSS WT. 8,581.297 KGS NET WT. 6617.226 KGS 02 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA 展開
交易日期
2025/06/23
提單編號
maeu254068114
供應(yīng)商
glenmark pharmaceuticals inc.
采購商
glenmark pharmaceuticals inc.
出口港
52330, salalah
進(jìn)口港
4601, new york/newark area, newark, nj
產(chǎn)品描述
14 PACKAGES 700 CARTONS PHAR MACEUTICALS AS UNDER DROSPI RENONE/EE TAB 3/0.03MG 84 NDC CODE:68462073329 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA N O.: 204848 THERAPEUTICE USE: - CONTRACEPTION TO PREVENT P REGNANCY COMMERCIAL & CUSTO M INVOICE NO. F22652000798 DT . 17.05.2025 S/BILL NO: 19478 80 DT:19/05/2025 GROSS WT. 2, 094.400 KGS NET WT.1,512.00 K GS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA 展開
交易日期
2025/06/23
提單編號
maeu254244878
供應(yīng)商
gland pharma
采購商
glenmark pharmaceuticals inc.
出口港
52330, salalah
進(jìn)口港
4601, new york/newark area, newark, nj
產(chǎn)品描述
PART OF FCL 5 PACKAGES 457 C ARTONS PHARMACEUTICALS AS UND ER BUMETANIDE INJECTION USP 2.5MG/10ML (0.25MG/ML) NDC N O. : 68462-470-54 FDA PRODUCT CODE : 64BCK09 ANDA NO. : 21 6434 H. T. S NO.: 3004.90.92 59 COMMERCIAL & CUSTOM INVO ICE NO. M72617000050 DT 06.05 .2025 S/BILL NO: 1741967 DT: 13/05/2025 GROSS WT. 2,461.83 0 KGS NET WT.2118.652 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC ., USA 301, ISLAND RD NEW JE RSEY MAHWAH USA- 07430 LABE LER CODE : 68462: 展開
交易日期
2025/06/23
提單編號
maeu253546362
供應(yīng)商
glenmark pharmaceuticals inc.
采購商
glenmark pharmaceuticals inc.
出口港
52330, salalah
進(jìn)口港
4601, new york/newark area, newark, nj
產(chǎn)品描述
PART OF FCL 15 PACKAGES 14 25 CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 40M G 500 NDC CODE:68462026405 6 1 J C A 16 3004.49.00.10 791 72 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DIS EASE ROSUVASTATIN TAB 40MG 30 NDC CODE:68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULA R DISEASE COMMERCIAL & CUST OM INVOICE NO. F22652000751 D T. 15.05.2025 S/BILL NO: 1863 197 DT 15-MAY-2025 GROSS WT. 4,421.489 KGS NET WT.3754.315 KGS 15 DATA LOGGERS HUMI DITY:65% SET TEMPERATURE : +1 8 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES N OTIFY PARTY:2 GLENMARK SPECIA LTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2 000 SWITZERLAND 展開
交易日期
2025/06/20
提單編號
yasvbom0072155
供應(yīng)商
glenmark pharmaceuticals inc.
采購商
glenmark pharmaceuticals inc.
出口港
53313, jawaharlal nehru
進(jìn)口港
1001, new york, ny